# Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations

> **NCT01777529** · PHASE4 · COMPLETED · sponsor: **The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)** · enrollment: 240 (actual)

## Conditions studied

- Measles
- Mumps
- Rubella

## Interventions

- **BIOLOGICAL:** MMR Vaccine

## Key facts

- **NCT ID:** NCT01777529
- **Lead sponsor:** The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-12
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01777529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01777529, "Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01777529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*